Paediatric Drug Content & Strength-Level Automation
Identified a content gap in Tata 1MG's paediatric drug pages — where products with different strengths shared generic content not tailored to strength-specific dosing and safety profiles.
Led the scoping and delivery of a strength-level entity model, enabling distinct content to be assigned and replicated across strength variants efficiently.
Expanded the scope to include paediatric vaccines.
The Challenge
- Strength-specific content variations across paediatric drugs required clinical accuracy at every level — not just copy-paste replication.
- Scaling across 20,000 SKUs within operational timelines required a semi-automated approach.
The Approach & Solution
- Scoped a strength-level entity model, defining the logic for what content should vary by strength vs inherit from the parent drug.
- Identified 80 Pareto drugs (highest traffic and business contribution) as the initial scope.
- Designed content templates and replication workflows, collaborating with writers and medical reviewers to validate strength-specific content.
Key Results & Commercial Impact
Technology Stack & Tools
Have a similar project in mind?
We specialize in custom AI systems, clinical data licensing pipelines, and scalable web apps. Let's build something exceptional together.
Explore More Projects
Google Health Partnership
Packaged clinical content as LLM training data, including drug monographs, DDI data, disease content, and regulatory safety data, in a B2B monetization deal.
Samsung Health API Integration
Real-time API integration spanning 600K+ SKUs, 50+ attributes, and a 200K-interaction DDI tool, enabling in-app discovery and routing cart/checkout to Tata 1mg.
Elsevier Clinical Monograph API Partnership
Tata 1mg's first clinical content licensing deal. Delivered 1,500 structured drug monographs over 9 months and built the CMS & API infrastructure.